ADRB2 and complex regional pain syndrome: CRPS patient serum contains autoantibodies targeting α1A-AR, β2-AR, and muscarinic-2 receptors [104,105], and the passive transfer of this serum to mice replicates CRPS-like symptoms [106,107,108,109,110].